Agilent Technologies Operating Income 2012-2025 | A
Agilent Technologies annual/quarterly operating income history and growth rate from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Agilent Technologies operating income for the quarter ending October 31, 2025 was $443M, a 8.58% increase year-over-year.
- Agilent Technologies operating income for the twelve months ending October 31, 2025 was $1.479B, a 0.6% decline year-over-year.
- Agilent Technologies annual operating income for 2025 was $1.479B, a 0.6% decline from 2024.
- Agilent Technologies annual operating income for 2024 was $1.488B, a 10.22% increase from 2023.
- Agilent Technologies annual operating income for 2023 was $1.35B, a 16.56% decline from 2022.
|
Agilent Technologies Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $1,479 |
| 2024 | $1,488 |
| 2023 | $1,350 |
| 2022 | $1,618 |
| 2021 | $1,347 |
| 2020 | $846 |
| 2019 | $941 |
| 2018 | $904 |
| 2017 | $807 |
| 2016 | $615 |
| 2015 | $522 |
| 2014 | $419 |
| 2013 | $386 |
| 2012 | $1,119 |
| 2011 | $1,071 |
|
Agilent Technologies Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-10-31 | $443 |
| 2025-07-31 | $360 |
| 2025-04-30 | $300 |
| 2025-01-31 | $376 |
| 2024-10-31 | $408 |
| 2024-07-31 | $333 |
| 2024-04-30 | $363 |
| 2024-01-31 | $384 |
| 2023-10-31 | $408 |
| 2023-07-31 | $133 |
| 2023-04-30 | $383 |
| 2023-01-31 | $426 |
| 2022-10-31 | $471 |
| 2022-07-31 | $411 |
| 2022-04-30 | $360 |
| 2022-01-31 | $376 |
| 2021-10-31 | $395 |
| 2021-07-31 | $336 |
| 2021-04-30 | $288 |
| 2021-01-31 | $328 |
| 2020-10-31 | $299 |
| 2020-07-31 | $230 |
| 2020-04-30 | $102 |
| 2020-01-31 | $215 |
| 2019-10-31 | $250 |
| 2019-07-31 | $225 |
| 2019-04-30 | $216 |
| 2019-01-31 | $250 |
| 2018-10-31 | $244 |
| 2018-07-31 | $221 |
| 2018-04-30 | $210 |
| 2018-01-31 | $229 |
| 2017-10-31 | $199 |
| 2017-07-31 | $201 |
| 2017-04-30 | $201 |
| 2017-01-31 | $206 |
| 2016-10-31 | $183 |
| 2016-07-31 | $146 |
| 2016-04-30 | $131 |
| 2016-01-31 | $155 |
| 2015-10-31 | $156 |
| 2015-07-31 | $144 |
| 2015-04-30 | $107 |
| 2015-01-31 | $115 |
| 2014-10-31 | $174 |
| 2014-07-31 | $131 |
| 2014-04-30 | $94 |
| 2014-01-31 | $124 |
| 2013-10-31 | $285 |
| 2013-07-31 | $236 |
| 2013-04-30 | $213 |
| 2013-01-31 | $217 |
| 2012-10-31 | $278 |
| 2012-07-31 | $270 |
| 2012-04-30 | $300 |
| 2012-01-31 | $271 |
| 2011-10-31 | $313 |
| 2011-07-31 | $281 |
| 2011-04-30 | $266 |
| 2011-01-31 | $211 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $39.599B | $6.948B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.159B | 25.14 |
| EssilorLuxottica (ESLOY) | France | $153.653B | 0.00 |
| Boston Scientific (BSX) | United States | $137.244B | 31.38 |
| Stryker (SYK) | United States | $135.412B | 26.89 |
| Medtronic (MDT) | Ireland | $128.035B | 17.74 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.403B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $38.246B | 18.29 |
| ResMed (RMD) | United States | $36.816B | 25.48 |
| Koninklijke Philips (PHG) | Netherlands | $25.633B | 16.74 |
| Terumo (TRUMY) | Japan | $21.631B | 24.35 |
| Insulet (PODD) | United States | $20.802B | 64.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.151B | 11.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.847B | 0.00 |
| Baxter (BAX) | United States | $9.844B | 7.95 |
| Sunny Optical Technology (SNPTF) | China | $9.054B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.312B | 29.89 |
| Demant (WILYY) | Denmark | $7.038B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.418B | 13.46 |
| Haemonetics (HAE) | United States | $3.908B | 17.39 |
| ICU Medical (ICUI) | United States | $3.664B | 23.26 |
| Envista Holdings (NVST) | United States | $3.612B | 20.73 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.954B | 13.47 |
| Curaleaf Holdings (CURLF) | Canada | $2.523B | 0.00 |
| AtriCure (ATRC) | United States | $2.107B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.011B | 88.14 |
| QuidelOrtho (QDEL) | United States | $1.956B | 12.58 |
| LeMaitre Vascular (LMAT) | United States | $1.906B | 38.36 |
| Perrigo (PRGO) | Ireland | $1.808B | 4.53 |
| Phibro Animal Health (PAHC) | United States | $1.627B | 16.25 |
| Kestra Medical Technologies (KMTS) | United States | $1.527B | 0.00 |
| Neogen (NEOG) | United States | $1.491B | 28.58 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Tilray Brands (TLRY) | Canada | $1.364B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.190B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 348.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.921B | 0.00 |
| InMode (INMD) | Israel | $0.917B | 10.36 |
| CeriBell (CBLL) | United States | $0.776B | 0.00 |
| Valneva SE (VALN) | France | $0.746B | 0.00 |
| Omeros (OMER) | United States | $0.720B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.641B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.607B | 0.00 |
| SNDL (SNDL) | Canada | $0.581B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.509B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.488B | 13.31 |
| Evolus (EOLS) | United States | $0.456B | 0.00 |
| BillionToOne (BLLN) | United States | $0.456B | 0.00 |
| Cerus (CERS) | United States | $0.419B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.365B | 0.00 |
| Quanterix (QTRX) | United States | $0.353B | 0.00 |
| Brainsway (BWAY) | Israel | $0.332B | 56.55 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.306B | 180.00 |
| TerrAscend (TSNDF) | Canada | $0.280B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 21.88 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Organigram Global (OGI) | Canada | $0.259B | 0.00 |
| High Tide (HITI) | Canada | $0.255B | 0.00 |
| Owens & Minor (OMI) | United States | $0.233B | 2.33 |
| Sanara MedTech (SMTI) | United States | $0.231B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.41 |
| OraSure Technologies (OSUR) | United States | $0.179B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.169B | 0.00 |
| Exagen (XGN) | United States | $0.161B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.156B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| Biote (BTMD) | United States | $0.123B | 5.40 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.122B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.29 |
| MacroGenics (MGNX) | United States | $0.089B | 0.00 |
| Sharps Technology (STSS) | United States | $0.076B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 23.89 |
| Nephros (NEPH) | United States | $0.053B | 38.62 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Veru (VERU) | United States | $0.035B | 0.00 |
| Jin Medical (ZJYL) | China | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.02 |
| Zynex (ZYXI) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |